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The cellular and molecular environment of the uterus during the pre- and peri-implantation period of 
early pregnancy is critical for implantation success and optimal fetal and placental development. 
Perturbations to this environment not only have consequences for the success of pregnancy and 
neonatal health and viability, but can also drive adverse health outcomes in the offspring after birth, 
particularly the development of metabolic disorders such as obesity, hypertension and insulin 
resistance. 
The influence of seminal plasma on the cytokine and immune uterine environment has been previously 
well characterised in mice, however the effects of disruption in uterine seminal plasma exposure for 
pregnancy outcome have not been investigated. The studies described in this thesis employed the use 
of surgical seminal vesicle ablation in males and embryo transfer experiments to investigate the 
physiological significance of uterine seminal plasma exposure on programming fetal and neonatal 
outcomes, and growth and metabolic status in adult offspring.  
We demonstrate that in the absence of seminal plasma, oocyte fertilisation and embryo implantation 
are reduced, showing that seminal plasma acts primarily to facilitate fertilisation, possibly by promoting 
sperm transport and survival in the reproductive tract. In addition we show that pregnancies initiated in 
the absence of seminal plasma give rise to offspring which display accelerated growth after birth and 
increased adiposity in adulthood, compared to those developed in a tract exposed to seminal plasma at 
the time of conception. Offspring conceived in the absence of seminal plasma also displayed alterations 
in serum leptin and adiponectin content, similar to those known to be associated with obesity in the 
mouse. 
Using embryo transfer experiments, we showed that some, but not all aspects of the perturbed 
postnatal development are recapitulated when embryos fertilised in the presence of what semen are 
transferred to a recipient tract which has not been exposed to seminal plasma. More severe 
perturbations were seen in 2-cell transfer than in blastocyst transfer experiment. Additionally, there was 
a significant effect of the embryo transfer procedure, irrespective of seminal plasma exposure, on fetal 
and postnatal development that confounded interpretation of these experiments. 
Bromfield   iIn addition, we investigated the potential mechanisms by which the influence of seminal plasma is 
exerted. Mediators of pre-implantation embryo development, implantation and the modulation of the 
maternal immune response to pregnancy were all assessed for regulation by seminal plasma using 
QRT-PCR. It was demonstrated that seminal plasma exposure induces the up-regulation of key 
embryotrophic factors, LIF, GM-CSF and IL-6, in the oviduct following insemination. Factors important 
in tissue remodelling required for implantation and angiogenesis, MMP-2, MMP-3 and VEGF-C, were 
also shown to be increased at the time of implantation after seminal plasma exposure. Additionally the 
generation of T-regulatory cells in uterine tissues, demonstrated by the up-regulation of the 
transcription factor FOXp3 was shown to be dependent on semen exposure. The influence of seminal 
plasma on embryonic development, implantation and modulation of the maternal immune response to 
pregnancy may therefore be mechanisms which contribute to the adverse outcomes seen in 
pregnancies initiated in the absence of seminal plasma. 
Together these experiments show a role for seminal plasma signalling at the time of insemination in 
influencing the pre-implantation embryo to program later fetal and neonatal development, thereby 
impacting on the metabolic health of offspring. We conclude that seminal plasma is not simply a 
transport medium for sperm, but acts also as a key regulator of a female tract environment providing 
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